Entrepreneur
Sex and the censorship: Raven Faber talks about the difficulties of online advertising
“If you start talking about female pleasure then everyone starts clutching their pearls. We can’t say vagina or run any adverts that support vulva pleasure.”

FemTech World speaks to Raven Faber founder of EngErotics about online censorship, sex tech standards and what needs to change
The slogan for this years’ International Women’s Day was #BreaktheBias. However, it remains difficult for femtech or sex tech companies to even attempt this on the very social media platforms promoting the hashtag.
Over 40 companies have signed a petition aimed at highlighting, and ending, the discrimination faced by female-founded companies online. The companies say their posts and accounts have been blocked, shadow banned and paid advertising banned due to explicit content – including posts on endometriosis, sex tech, vagina health and other female-centric content.
Raven Faber founded EngErotics with the aim of moving into well-designed, accessible sex tech. She also began to include CBD in her business through different self-care products that enhance the experience for users. However, with the increase in online censorship, we ask if being in the cannabis industry and the sex tech industry has been difficult.
She said: “When I started EngErotics, I didn’t realise we were going to enter into cannabis as it was strictly sex tech because that’s what I knew. I didn’t know anything about CBD because I had been working in the corporate world where there were zero-tolerance policies.”
When a client reached out to Raven, she began researching what CBD was and also how it could be combined with sex tech to improve a user’s experience. Through research, she noticed that there was a huge issue with consistent quality and standards in the cannabis industry which was similar to the sex device market.
Raven said: “I discovered, similar to what we see in the intimate device work of sex toys that there were no design standards. There were no formulation standards as it was very much the wild west with no checks or accountability for quality, safety or efficacy. This was another place for engineering and tech to shine to help bring good practise and accountability into the industry.”
Online censorship
In the past few months, campaigns have been launched around the censorship experienced by sex tech or femtech companies online. This includes adverts being removed, social media posts taken down, accounts blocked and banned. Femtech companies are arguing that this has a huge effect on the industry – especially for women- as bans have included products specially designed for women. However, adverts for male products do not struggle with the same level of bans.

In a survey, the Centre for Intimacy Justice found that 60 per cent of femtech companies had had an advert removed by Facebook/Meta. Half of the companies who participated had had their accounts removed by Facebook while 100 per cent had had an advert rejected by Instagram.
Raven remembers how difficult advertising was when she started. After hearing reports of how difficult it was to advertise, she decided to use a grassroots approach with Facebook in comparison to a multi-platform advertising strategy or paid advertising.
She said: “I didn’t really bother with paid advertising as I was hearing from other people that they were having a rough time with it. People were having their social accounts shut down so I did the best that I could. We didn’t have an Instagram or Twitter for a long time but we had a Facebook page where people could find us.”
While Meta platforms cannot stop every account that features sex or fem tech, bots look for certain words to flag from obvious choices such as cannabis or sex to the more unusual word, men. It has led to influencers changing the way they spell certain words to avoid triggering a bot response. This is why accounts use words such as s3x, oud or m3n instead of the actual spelling.
Raven said: “In the beginning, it was just me making things up and hoping it would work. I didn’t censor myself so I would spell sex correctly or not abbreviate the word orgasm. We had to be very careful not to post anything explicit or show pictures of the toys or nudity. Maybe it would be a pretty picture of a black woman with a suggestive copy.”
She added: “How could we put this out there in a way that is going to look benign enough where we do not get shut down because so far our account hasn’t been closed. A lot of our growth has been organic, I never bothered with throwing money into paid advertising because a lot of people were getting shut down anyway.”
Social media censorship
Often with smaller, independent or start-up companies, social media can provide a valuable link between customers and businesses. It’s essential in a world where PR campaigns can be too costly for emerging entrepreneurs or start-ups.
Raven explained: “Social media platforms are necessary evils. It’s where people go looking for you now. I’m not against social media but I hate being told what I can and can’t say when it comes to sexual education because it’s important. However, when you deal with industries that are considered to be vice then this is what you run into.”
Vice industries is the term increasingly used to describe the sex toy, adult pleasure, sex tech and cannabis worlds. In many ways, it can feel like a community where the two have almost identical problems such as bans and banking. They can overlap in many ways when it comes to censorship.
Raven said: “It took us over a year to find a merchant processor. There are a lot of people who struggle to find banking in the intimacy device and cannabis industries. I lucked out because when I opened my business, I named it, registered it and got my tax ID before I started making a product. No one told me to do that but it made sense to do it that way. I saved myself a lot of pain by getting in good with a bank first.”
She added: “If you are looking to hire contractors then there may be certain ones that won’t work with you because of the industry you are in. If it’s not the sex tech then it’s the CBD. There have been a handful of people who don’t feel comfortable providing the service because you sell vibrators because of the stigma. It’s all about the perception of what is seen to be shameful or vice. They worry that it will rub off on them and tarnish their reputation.”
The perception of the vice industry and the stigma has also had a huge effect on brands during the pandemic. Vice brands in the cannabis and fem/sex tech worlds were denied a loan during Covid to help with staffing costs or keep businesses alive.
“In 2020, the government gave out loans to businesses that qualified during Covid but businesses they defined as lewd didn’t qualify for assistance. This could include owners of strip clubs trying to pay their bartenders or adult pleasure stores that couldn’t get help. Getting a loan can be really difficult,” Raven said.
“The activity I saw on social media during this time from business owners was that those offering intimacy devices were running into brick walls because the definition of what was defined as a ‘lewd’ business was too broad and subjective. It affected everyone from those who had brick and mortar stores to e-commerce or potentially even sex therapists too. A lot of people didn’t qualify and they were hurting.”
“The funny this was, that a lot of politicians or government workers were enjoying the products they were stigmatising. A lot of my peers in this industry had people on a payroll that they couldn’t afford to pay because they didn’t qualify for this loan.”
The sex tech industry has taken massive steps into the wellness industry in recent years. The backstreet stores and dodgy websites have been replaced by glossy marketing campaigns, well-packaged items with self-care instructions or free chocolates. The vibe in modern times seems to be more focused on masturbation as a part of your wellness and self-care routine making sex tech less scary or inaccessible to all.
Industry progression
But while the industry goes forward, the advertising channels and options seem to be going backwards.
Raven said: “It’s really backwards in that you can’t advertise now. There are some companies that get away with it but a lot of the smaller ones cannot. It’s really unhelpful because you know exactly what a good campaign can do. You pump money into your ad spend with a campaign to increase your reach substantially but it’s hard. It’s difficult to get organic growth and traction.”
She added: “It’s sex educators too who are having their accounts closed down. It’s good educational stuff to do with sex which is so badly needed. It’s heavily biased in that if we are talking about men then you can run ads for erectile dysfunction medication or erectile devices. But if you start talking about female pleasure then everyone starts clutching their pearls. We can’t say vagina or run any adverts that support vulva pleasure.”
When it comes to moving forward, Raven is focusing on the journey rather than the number of followers. She believes the smaller numbers of genuine fans or customers are better than the larger audience.
Raven said: “It takes a lot of tenancy to go after that organic growth. Do we have 40,000 followers on our Instagram? No, but we will get there after a while. What I have noticed with those who follow us is that they are really into what we do. If we have 1000 followers then 60 per cent of those are actual customers in comparison to those accounts with thousands of followers where no one buys a thing.
Make no mistake, social is important. Due to the obstacles and the red tape, I’ve been focusing more on the journey, and the quality rather than the quantity.”
Read more: Sword Health launches bloom: a new pelvic pain product
Entrepreneur
Women’s Health Week USA confirms full speaker lineup and records 170 pitch applications

By Women’s Health Week
With four weeks to go until Women’s Health Week USA, the excitement is ramping up!
The final early bird pricing closes this Friday, the full speaker lineup is confirmed, and a record number of pitch applications signals the depth of innovation now moving through the sector as we enter the Era of Scale.
Women’s Health Week USA takes place May 13-14 at the New York Academy of Medicine in New York City, bringing together 600+ senior decision makers spanning investors, founders, multinationals, payers, providers and policymakers around one shared agenda: taking women’s health from growth to scale.
Early bird tickets are available until midnight on Friday, April 17.
Book by then to save up to $600 on your place
The Full Speaker Lineup is Confirmed
The full speaker lineup has finally been confirmed, with 80+ voices spanning investment, innovation, policy, medtech and pharma.
The programme reflects the event’s 2026 theme, The Era of Scale, moving beyond early validation into the harder work of institutionalising women’s health as a category.
Confirmed speakers include Kate Ryder (Maven Clinic), Mallika Mundkur (FDA), Melanie Newman (Planned Parenthood), Nichole Young-Lin (Google), Jill Angelo (OURA), David Stern (Kindbody) and Tammy Sun (Carrot Fertility), alongside representation from the NYSE, ARPA-H, the World Health Organization, Samsung Next, Novo Holdings and more.
170 Pitch Applications and Counting
The Women’s Health Week USA Innovation Showcase received a record 170 applications ahead of its April 10 close, the highest number in the event’s history.
The volume reflects the growing depth of innovation in the sector, but it was the quality of submissions that stood out, with companies across Medical Devices & Therapeutics and Consumer & Tech bringing genuinely differentiated solutions to conditions that have been underserved for decades.
The selected companies will get the chance to pitch on the mainstage at the New York Academy of Medicine in front of the full audience of 600+ investors, corporates, innovators and strategic partners.
Results will be announced next week.
Register your interest to find out who makes the WHW USA Innovator Class of 2026
NYSE Partnership: A Quick Recap
For those who missed our announcement on Femtech World last week, the New York Stock Exchange is the Official Exchange Partner of Women’s Health Week USA 2026.
On the morning of May 13, WHW will feature in the NYSE Market Update, reaching approximately 200 million viewers.
Women’s Health Week will also light up the North Star Billboard in Times Square for a full week around the event, with live and taped interviews distributed across NYSE Live and Taking Stock.
It remains one of the most significant institutional endorsements the women’s health sector has seen.
Early Bird Pricing Closes This Friday
Tickets increase by up to $600 after midnight on Friday, April 17. For anyone with May 13-14 in their calendar, this week is the window to move.
Entrepreneur
Flora Fertility closes US$5m seed round

Flora Fertility has raised US$5m in seed funding to roll out fertility insurance across the US, with plans to expand into Canada.
The round was led by ManchesterStory, with participation from Slauson & Co., TruStage Ventures, BDC Capital, Marathon Fund, Adara Venture Capital and strategic angel investors. Existing investors include Highline Beta, Everywhere Ventures and Cartography Capital.
Laura McDonald, co-founder of Flora Fertility, said: “Fertility is one of the largest uninsured financial risks people face, yet the system today only offers support once you’re already in crisis and often only if your employer provides it.
“We’re creating a new category where fertility becomes something you can proactively plan for, not just pay for when it’s too late.”
Flora says it is introducing a new InsurTech category with individually owned, portable fertility insurance designed to address a gap in healthcare cover.
The company says it wants to shift fertility from a reactive expense to a proactive, data-driven financial planning tool, using AI, personalised underwriting and risk modelling.
The platform lets people buy coverage without relying on an employer, helping it continue through job changes and different stages of life.
Flora’s policies cover a full range of fertility treatments, including diagnostics, medications, intrauterine insemination and in vitro fertilisation, with entry-level pricing starting at about US$20 a month.
The company estimates that infertility affects one in six people globally, while treatment costs can range from US$30,000 to US$50,000, leaving the vast majority of patients without access to care.
Flora says its platform currently reaches more than 10 million prospective policyholders across North America.
The funding will be used to expand Flora’s underwriting capabilities, scale distribution and further develop its platform as it seeks to establish a new market within women’s health and insurance.
Nicole Gunderson, partner at ManchesterStory, said: “Flora is building something that has never existed before, affordable, portable fertility insurance that meets the next generation of women exactly where they are.
“The InsurTech opportunity here is enormous, and the Flora team has the expertise, technology, and vision to define this category.”
Dr Christy Lane, co-founder of Flora Fertility, added: “Fertility has always been treated as unpredictable and uninsurable, but the data tells a different story.
“The earlier someone can access that coverage, the better their outcomes and the lower their costs, which is what makes this model so powerful.
“We’re turning fertility from a reactive medical expense into a proactive, data-driven financial decision.”
Entrepreneur
New York Stock Exchange backs Women’s Health Week USA

By Women’s Health Week
When the New York Stock Exchange signs on as the Official Exchange Partner of a women’s health event, it’s worth paying attention to.
Women’s Health Week USA, taking place May 13-14 at the New York Academy of Medicine in New York City, has confirmed the NYSE as its Official Exchange Partner for 2026.
It is one of the most significant institutional endorsements the women’s health sector has seen, and it says something meaningful about where global capital markets are directing their attention.
Find out more about WHW USA 2026 here.
What the Partnership Involves
This is not simply a logo on a lanyard.
The NYSE partnership comes with a set of activations that put women’s health in front of audiences well beyond the event itself.
On the morning of May 13, Women’s Health Week will be featured in the NYSE Market Update, reaching an audience of approximately 200 million viewers across outlets including Yahoo Finance and the Financial Times.
For a sector that has historically struggled for mainstream financial visibility, that kind of reach is significant.
Women’s Health Week will also light up the North Star Billboard in Times Square for a full week around the event, placing the brand at the centre of one of the most commercially visible locations in the world.
NYSE will produce live and taped interviews with WHW leadership and keynote speakers, distributed across NYSE Live, Taking Stock, and partner platforms reaching tens of millions of viewers monthly.
A dedicated NYSE content team will be on the ground at the New York Academy of Medicine capturing the conversations and connections taking place across both days.
The NYSE’s Healthcare & Life Sciences team will also take to the stage at Women’s Health Week USA, sharing their perspective on trends shaping the sector from a capital markets standpoint.
Why It Matters
The partnership is a signal as much as it is a sponsorship.
Women’s health has spent years making the case that it is a commercially serious category.
The NYSE’s involvement makes that case in a language the broader financial world understands.
Women’s Health Week USA 2026 is themed around The Era of Scale, a deliberate framing around the idea that the sector has moved beyond early validation into the harder work of institutionalisation.
Capital is moving. M&A activity is increasing. Generalist investors are entering a space that was once left to specialists. The NYSE partnership fits neatly into that narrative.
With 600+ senior decision makers confirmed across investors, founders, multinationals, payers and policymakers, the event is already one of the most commercially concentrated gatherings in the women’s health calendar.
The NYSE’s reach extends that concentration well beyond the walls of the New York Academy of Medicine.
Find out for yourself why this partnership is so perfect and join Women’s Health Week USA. Secure your ticket here.
The Pitch Sessions
For founders and early-stage companies, Women’s Health Week USA also hosts a mainstage Pitch Session across two categories: Medical Devices & Therapeutics and Consumer & Tech. Fifteen companies will be selected to pitch in front of the full audience.
Applications close April 10.
They are free to submit, and any company working on a condition that affects women exclusively, differently, or disproportionately is eligible.
Entrepreneur3 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause4 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News3 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Entrepreneur3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
News4 weeks agoEndometriosis firm wins NIH prize







